Sellas Life Sciences Group Inc.
Featured video - SELLAS Reports Preliminary Data Showing Clinical[...]
Safety and Efficacy of Pegunigalsidase Alfa vs Agalsidase Beta on Renal[...]
Safety and efficacy of pegunigalsidase alfa vs agalsidase beta on renal[...]
01/24/2022 | Press release | Distributed by Public on 01/24/2022 16:06
Please select the service you want to use:
Smartlinks | SolarWindow Technologies Inc. | News | Education | Local News | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Shareholders | Consumer Electronics | Manufacturing | Lifestyle and Leisure | Leisure | Public Companies | Photovoltaic and Solar Equipment Companies | London Stock Exchange (LSE) | Börse Berlin | Börse München | Börse Stuttgart | OTC Markets
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact